Tyra Biosciences, Inc. 4

Rehan Verjee purchased approximately 972 shares of Tyra Biosciences, Inc. common stock for about $20,000 in open-market transactions.

On September 9, 2026, insider Rehan Verjee acquired 971.8943 shares of Tyra Biosciences, Inc. common stock in the open market at a weighted average price of approximately $20.58 per share, with individual trade prices ranging from $20.5550 to $20.6488. The transaction, reported as an acquisition in a direct ownership capacity, represents an estimated purchase of about $20,000 worth of stock and reflects an increase in the reporting person's directly held position, though the exact total number of shares beneficially owned after the transaction is not provided in the filing excerpt.

Filing Facts

CIK

1863127

Ticker

TYRA

Form

4

Source Type

fda

Accession

0001193125-26-389333

Alert Tier

6